Martin Yang, Oppenheimer senior analyst, joins 'Squawk on the Street' to discuss what Apple Intelligence is lacking that's ...
Shares of Apple have surged roughly 40% over the past nine months, but one analyst issued a cautious warning that it’s time ...
Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...
Investors were hoping that Apple Intelligence would drive a wave of iPhone upgrades. How's that playing out? This will be the first full quarter of results from Apple since the company's iPhone 16 ...
Apple shares rose more than 3% in premarket trading on Friday after the company forecast relatively strong sales growth, hinting at a recovery from a dip in iPhone sales as it rolls out artificial ...